NF2 and cancer: Together, this suggests that the observed differences in sensitivity to FAK inhibition between the pancreatic PDCLs may be associated with different levels of Merlin expression, where low Merlin expression may be linked to improved response to FAKi, in line with preclinical and clinical studies in other cancers (20, 21).